Propionic Acid

Propionic Acid

SCHEMBL4155193

CCC(=O)O.O=c1[nH]c2ccc(S(=O)(=O)O)cc2c2cc[nH]c12

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.41
PARP1 P09874 4/20 0.39
KDM4E B2RXH2 5/20 0.39
PTPN11 Q06124 6/20 0.39
ALDH1A1 P00352 2/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
F2 P00734 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
HPGD P15428 1/20 0.37
PTGS1 P23219 1/20 0.37
KDR P35968 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4162918 0.89 BRAF (0.46) RXFP1KDM4EMAPTCDK1CDK2
Propionic Acid SCHEMBL4160658 0.87 TAS2R14 (0.49) RXFP1PARP1KDM4EALDH1A1GRIN2D
Propionic Acid SCHEMBL4162945 0.87 KDM4E (0.47) RXFP1KDM4EPTPN11ALDH1A1GRIN2D
Propionic Acid SCHEMBL4174066 0.87 KDM4E (0.54) KDM4EALDH1A1MAPTHPGDTDP1
Propionic Acid SCHEMBL4155190 0.85 PTGS2 (0.40) RXFP1PARP1KDM4EALDH1A1GRIN2D
Propionic Acid SCHEMBL4174097 0.85 HSD17B10 (0.55) KDM4EALDH1A1MAPTHPGDKDR
Propionic Acid SCHEMBL4162521 0.85 FEN1 (0.44) RXFP1PARP1KDM4EALDH1A1MAPT
Propionic Acid SCHEMBL4157681 0.84 GAA (0.54) KDM4EALDH1A1MAPTHPGDKDR
Propionic Acid SCHEMBL4163285 0.84 PKM (0.54) PARP1MAPTTDP1BRAFPOLB
Propionic Acid SCHEMBL4160991 0.84 BRD4 (0.39) RXFP1PARP1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 RXFP1 3999/4885PARP1 628/4885KDM4E 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.